The Translational Award supports the development of cardiovascular technologies from the proof-of-concept stage to being ready for the commerical market. 

  • Projects should be in the field of cardiovascular disease, stroke, vascular dementia and diabetes.
  • The award can be used for development of therapeutics, medical devices, imaging technologies, diagnostics and digital solutions. 

Projects should:

  • be novel, inventive and address and unmet clinical need.
  • have demonstrated proof of principle.
  • result in a product, technology or intervention that's ready for market development. 

All preliminary applications will be considered by the Translational Awards Committee. Successful applicants will be invited to submit a full application. 

 

For the application and further details email the team at researchtranslation@bhf.org.uk 

First published: 3 March 2021

<< December - February 2021